首页热门标签study(817)
    {tag_tag图片标签}
PMI’s Latest Clinical Results: Findings Add to Extensive Evidence Pack
Likely the first ever clinical study of this magnitude to directly assess ri...
2018-06-17 文传商讯
Boehringer Ingelheim starts clinical study on interchangeability betwee
First patient enrolled into VOLTAIRE-X; an interchangeability study designed...
2017-07-31 文传商讯
Boehringer Ingelheim presents phase III results demonstrating clinical
Pivotal Phase III study results for biosimilar candidate BI 695501 will be p...
2017-06-16 文传商讯
Latest clinical research confirms that IQOS reduces smoker exposure to
Studies conducted to date clearly indicate that IQOS is likely to present le...
2017-03-29 文传商讯
Boehringer Ingelheim bevacizumab biosimilar candidate demonstrates bioe
Phase I study shows bioequivalence between BI 695502 and Avastin® (bevac...
2016-11-18 文传商讯
Patient enrolment completed for RE-DUAL PCI study assessing dabigatran
Over 2,700 atrial fibrillation (AF) patients undergoing a percutaneous coron...
2016-11-16 文传商讯
SES Reaches 2.81 Million TV Homes in Nigeria, New Study Reveals
Satellite growth and accessibility will accelerate digital broadcasting in N...
2016-06-24 文传商讯
SES Expands Its Reach to Two Million TV Homes in Ghana
SES reaches two million TV homes in Ghana, an overall growth of 18% since 20...
2016-06-01 文传商讯
Boehringer Ingelheim launches RE-COVERY DVT/PE TM: global observational
First patient enrolled in RE-COVERY DVT/PE™Involving 14,000 patients w...
2016-03-24 文传商讯
Nearly 14% of Deals Covered by M&A Insurance Resulted in a Claim, Accor
Global Claims Data Study Spans Policies for approximately 1,000 Deals, Worth...
2016-02-26 文传商讯
总数:10 首页上一页下一页尾页 页次:1/1

推荐图片信息

    {tag_侧栏推荐图片信息}

热点信息

    {tag_侧栏热点信息}
网站首页 | 关于我们 | 联系方式 | 招聘信息 | 版权声明 | 网站地图
太平洋品牌网
太平洋品牌网 - 网罗全球品牌资讯,是全国品牌网站中的十大品牌网
广告合作QQ:480335193 | 邮箱:480335193@qq.com
免责声明:太平洋品牌网所有文字、图片、视频、音频等资料均来自互联网,不代表本站赞同其观点,本站亦不为其版权负责。相关作品的原创性、文中陈述文字以及内容数据庞杂本站无法一一核实,如果您发现本网站上有侵犯您的合法权益的内容,请联系我们,本网站将立即予以删除!
ICP备案号:闽ICP备1234578896 Copyright © 2012-2017 PCbrand.com.cn, All rights reserved.